Wuhan Hygeianey Biological Technology co., LTD

Technology
Current location:
Home page
>
Molecular Diagnostic Platform
All categories
Information

Accurate medical testing technology platform

Accurate medicine is based on individualized medicine, a kind of new medical concept and medical model developed by cross application of genome sequencing technology and biological information and large data science. Wuhan Hygeianey Biological Technology co., LTD is established in accurate medical industry, devotes into research and development of individualized diagnosis reagent, uses diversified testing platforms (Q-PCR platform, ddPCR platform, NGS platform, ACTC platform etc.), covers tumor early prediction, tumor curative effect evaluation, tumor drug diagnosis, cardiovascular drug diagnosis, prenatal and postnatal care and other fields.

Q-PCR(Real-time Quantitative PCR Detecting System) testing platform

  Q-PCR platform of Hygeianey uses unique patented ARMS+PNA(Amplification Refractory mutation System + Peptide Nucleic Acids) technology, which is one of the most important and advanced technologies of individual molecular detection in the world, and its advantage in the clinical application is approved by experts in the industry. PNA technology blocks wild type template amplification and ARMS technology implements specific amplification mutant DNA fragments using high specificity of PCR primer 3’ end.

ddPCR(Droplet Digital PCR) testing platform

ddPCR conducts droplet processing for samples before traditional PCR amplification, that is, to divide the reaction system containing nucleic acid molecules into thousands of nano flow droplets, in which each droplet does not contain or contain one or several nucleic acid molecular targets to be tested. Hygeianey ddPCR platform has the 1/10000 level of detection sensitivity, easy and simple workflow, high throughput sample processing capacity, and it is widely applied to various gene mutation detection, gene expression analysis fields.

NGS(Next Generation Sequencing)testing platform

  NGS is namely massively parallel sequencing, including many sequencing techniques being capability of producing a large number of digital gene sequences one-time, is the revolutionary progress following Sanger sequencing. It can sequence millions or even billions of DNA molecules, achieving the purpose of large-scale and high-throughput sequencing. NGS testing platform of Hygeianey tests gene sequence depending on ABI sequencing platform, and it is widely applied to individualized therapy field, including tumor individualized drug and therapy monitoring, diagnosis of genetic disease and risk screening noninvasive prenatal genetic testing etc.. 

ACTC(Accurate Capture of Tumor Cells)testing

NGS is namely massively parallel sequencing, including many sequencing techniques being capability of producing a large number of digital gene sequences one-time, is the revolutionary progress following Sanger sequencing. It can sequence millions or even billions of DNA molecules, achieving the purpose of large-scale and high-throughput sequencing. NGS testing platform of Hygeianey tests gene sequence depending on ABI sequencing platform, and it is widely applied to individualized therapy field, including tumor individualized drug and therapy monitoring, diagnosis of genetic disease and risk screening noninvasive prenatal genetic testing etc..

 

Molecular Diagnostic Platform

Copyright©Wuhan Hygeianey Biological Technology Co., LTD